CK Life Sciences Int'l., (Holdings) Inc. LSI.F Stock
CK Life Sciences Int'l., (Holdings) Inc. Price Chart
CK Life Sciences Int'l., (Holdings) Inc. LSI.F Financial and Trading Overview
Contents
CK Life Sciences Int'l., (Holdings) Inc. stock price | 0.04 EUR |
Previous Close | 0.08 EUR |
Open | 0.08 EUR |
Bid | 0.08 EUR x 5270000 |
Ask | 0.09 EUR x 5270000 |
Day's Range | 0.08 - 0.08 EUR |
52 Week Range | 0.07 - 0.11 EUR |
Volume | 8 EUR |
Avg. Volume | 0 EUR |
Market Cap | 858.23M EUR |
Beta (5Y Monthly) | 0.524137 |
PE Ratio (TTM) | Infinity |
EPS (TTM) | 0 EUR |
Forward Dividend & Yield | 0 (1.19%) |
Ex-Dividend Date | May 23, 2023 |
1y Target Est | N/A |
LSI.F Valuation Measures
Enterprise Value | 6B EUR |
Trailing P/E | Infinity |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.16267914 |
Price/Book (mrq) | 0.18937644 |
Enterprise Value/Revenue | 1.138 |
Enterprise Value/EBITDA | 15.246 |
Trading Information
CK Life Sciences Int'l., (Holdings) Inc. Stock Price History
Beta (5Y Monthly) | 0.524137 |
52-Week Change | 10.27% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.11 EUR |
52 Week Low | 0.07 EUR |
50-Day Moving Average | 0.09 EUR |
200-Day Moving Average | 0.08 EUR |
LSI.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 9.61B |
Float | 2.4B |
Short Ratio | N/A |
% Held by Insiders | 74.98% |
% Held by Institutions | 1.15% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.008 |
Trailing Annual Dividend Yield | 9.93% |
5 Year Average Dividend Yield | 167.00% |
Payout Ratio | 0.7299 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 2.50% |
Operating Margin (ttm) | 4.54% |
Gross Margin | 30.82% |
EBITDA Margin | 7.46% |
Management Effectiveness
Return on Assets (ttm) | 1.30% |
Return on Equity (ttm) | 3.04% |
Income Statement
Revenue (ttm) | 5.28B EUR |
Revenue Per Share (ttm) | 0.55 EUR |
Quarterly Revenue Growth (yoy) | -1.00000000000000000000000000000000% |
Gross Profit (ttm) | 1.63B EUR |
EBITDA | 393.78M EUR |
Net Income Avi to Common (ttm) | 131.96M EUR |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | 7.09% |
Balance Sheet
Total Cash (mrq) | 704.12M EUR |
Total Cash Per Share (mrq) | 0.07 EUR |
Total Debt (mrq) | 5.95B EUR |
Total Debt/Equity (mrq) | 143.09 EUR |
Current Ratio (mrq) | 0.769 |
Book Value Per Share (mrq) | 0.433 |
Cash Flow Statement
Operating Cash Flow (ttm) | 363.66M EUR |
Levered Free Cash Flow (ttm) | 90.23M EUR |
Profile of CK Life Sciences Int'l., (Holdings) Inc.
Country | Germany |
State | N/A |
City | Tai Po |
Address | 2 Dai Fu Street |
ZIP | N/A |
Phone | 852 2126 1212 |
Website | https://www.ck-lifesciences.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 1856 |
CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; licensing of registration activities and the importation of finished agricultural goods; holding of land and buildings; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products. In addition, it distributes turf management machinery, hardware, equipment, and accessories, as well as turf fertilizers, chemicals, and professional pest products; produces, refines, and distributes salt products; and provides research and development services for biotechnology and life sciences technology products. Further, it researches, develops, manufactures, and commercializes drug products to treat pain and melanoma; supplies raw materials for nutritional health, pharmaceutical, cosmetics, personal care, and food segments; and offers packing and asset management services. The company was founded in 1999 and is headquartered in Tai Po, Hong Kong.
Q&A For CK Life Sciences Int'l., (Holdings) Inc. Stock
What is a current LSI.F stock price?
CK Life Sciences Int'l., (Holdings) Inc. LSI.F stock price today per share is 0.04 EUR.
How to purchase CK Life Sciences Int'l., (Holdings) Inc. stock?
You can buy LSI.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CK Life Sciences Int'l., (Holdings) Inc.?
The stock symbol or ticker of CK Life Sciences Int'l., (Holdings) Inc. is LSI.F.
Which industry does the CK Life Sciences Int'l., (Holdings) Inc. company belong to?
The CK Life Sciences Int'l., (Holdings) Inc. industry is Biotechnology.
How many shares does CK Life Sciences Int'l., (Holdings) Inc. have in circulation?
The max supply of CK Life Sciences Int'l., (Holdings) Inc. shares is 10.98B.
What is CK Life Sciences Int'l., (Holdings) Inc. Price to Earnings Ratio (PE Ratio)?
CK Life Sciences Int'l., (Holdings) Inc. PE Ratio is now.
What was CK Life Sciences Int'l., (Holdings) Inc. earnings per share over the trailing 12 months (TTM)?
CK Life Sciences Int'l., (Holdings) Inc. EPS is 0 EUR over the trailing 12 months.
Which sector does the CK Life Sciences Int'l., (Holdings) Inc. company belong to?
The CK Life Sciences Int'l., (Holdings) Inc. sector is Healthcare.